summary
Introduced
01/09/2019
01/09/2019
In Committee
01/09/2019
01/09/2019
Crossed Over
Passed
Dead
04/08/2019
04/08/2019
Introduced Session
2019 Regular Session
Bill Summary
Encouraging the Natalie M. LaPrade Medical Cannabis Commission to approve provider applications for patients who have an opioid use disorder.
AI Summary
This bill encourages the Natalie M. LaPrade Medical Cannabis Commission to approve provider applications for patients who have an opioid use disorder. The bill amends the existing law to add "an opioid use disorder" as a condition for which the Commission is encouraged to approve provider applications, alongside other chronic or debilitating diseases or medical conditions. The bill aims to increase access to medical cannabis as a treatment option for individuals with opioid use disorder, which has become a significant public health issue in Maryland and across the United States.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Hearing 1/29 at 2:00 p.m. (on 01/22/2019)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0033?ys=2019rs |
| State Bill Page | http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb0033&stab=01&pid=billpage&tab=subject3&ys=2019rs |
| Fiscal Note/Analysis | http://mgaleg.maryland.gov/2019RS/fnotes/bil_0003/hb0033.pdf |
| BillText | http://mgaleg.maryland.gov/2019RS/bills/hb/hb0033f.pdf |
Loading...